Evidence map›Paper›PMID 40001055›Full record

ArticleBMC health services research2025

Investigating facilitators and barriers to the routine provision of HIV PrEP in community pharmacies in London.

Marsha Alter, Shivali Lakhani, Aos Alaa, Manisha Karki, Eva Riboli-Sasco, Austen El-Osta

Abstract read
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marsha AlterSchool of Public Health, Imperial College, London, UK. m.alter@imperial.ac.uk.ORCID http://orcid.org/0000-0001-5662-7943
Shivali LakhaniSchool of Public Health, Imperial College, London, UK.ORCID http://orcid.org/0000-0002-5930-1292
Aos AlaaSelf-Care Academic Research Unit (SCARU), School of Public Health, Imperial College, London, UK.ORCID http://orcid.org/0000-0001-6130-5092
Manisha KarkiSelf-Care Academic Research Unit (SCARU), School of Public Health, Imperial College, London, UK.ORCID http://orcid.org/0000-0001-6996-8915
Eva Riboli-SascoSelf-Care Academic Research Unit (SCARU), School of Public Health, Imperial College, London, UK.ORCID http://orcid.org/0000-0002-9922-9125
Austen El-OstaSelf-Care Academic Research Unit (SCARU), School of Public Health, Imperial College, London, UK.ORCID http://orcid.org/0000-0002-8772-4938

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe United Kingdom's (UK) integration of Pre-exposure Prophylaxis (PrEP) into community pharmacies presents an alternative avenue for supporting Human Immunodeficiency Virus (HIV) prevention. Despite its effectiveness, PrEP's accessibility remains hindered by various barriers within community settings. The aim of this study was to explore the perspectives of pharmacy team members regarding the barriers and facilitators to the routine provision of PrEP in community pharmacies in the UK, as well as any recommendations for mitigating these challenges.

methodsExploratory mixed-method cross-sectional study utilising an online survey and semi-structured interviews with community pharmacists and non-pharmacist team members across the North Thames area of London, England. A convenience sample of 110 pharmacy team members participated in the study, including both pharmacists and non-pharmacists. Two pharmacy technicians and eight pharmacists took part in semi-structured interviews. Data collection involved a cross-sectional online survey and semi-structured interviews. The survey collected data such as demographic characteristics, knowledge, and attitudes towards PrEP provision, while interviews explored in-depth perceptions, experiences and recommendations.

resultsA significant proportion of respondents expressed a lack of confidence and knowledge regarding PrEP, with training identified as a critical need for facilitating PrEP provision. Additionally, the study highlighted the potential of community pharmacies to increase accessibility of PrEP due to their geographical reach and the trust placed in pharmacists.

conclusionThe study demonstrates an interest from community pharmacies in London in providing a commissioned PrEP supply service. However, this would need to be in conjunction with training programmes and public health campaigns to equip community pharmacies for effective PrEP provision. Enhancing pharmacists' competencies and raising public awareness could significantly support the current HIV prevention strategies in the UK.

Indexed as

Anti-HIV AgentsCommunity Pharmacy ServicesHealth Services AccessibilityHIV InfectionsPre-Exposure ProphylaxisAdultAttitude of Health PersonnelCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansInterviews as TopicLondonMaleMiddle AgedPharmacistsAnti-HIV AgentsCommunity pharmacyHIVPharmacyPrEPSexual health

Identifiers

PMID40001055
PMCPMC11863588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.